|
|

This is only a preview of the paper Click here to register and get the full text. Existing members click here to login
|
|
|
Saharan Africa is made up of about ten percent of the worlds population. ... Only in Sub-Saharan Africa is this epidemic not concentrated to certain risk groups. ... With no funds being generated for educational investment, and a region that has cultural obstacles in the way of finding a solution to the prevention of HIV/AIDS, there is little hope if nothing is improved. Due to poor economic conditions and lack of ethical behaviors, Sub-Saharan Africa is losing its fight against HIV/AIDS. ...
Most of the countries in Sub-Saharan Africa just recently gained their independence from overruling foreign governments. ...
Over the past thirty to forty years, Sub-Saharan Africa has taken a substantial loss in their export market. ... Sub-Saharan Africa has implemented import tariffs that are about "three times those of the fast-growing exporters, and more than four times the OECD average" (Amjadi). ...
Redefining the HIV/AIDS epidemic in Sub-Saharan Africa as a public health and infectious disease emergency is a start. ... Should companies be able to conduct testing of experimental drugs in Africa? ... Research in developing countries such as Africa brings into play the concerns of taking advantage of the "vulnerabilities created by poverty and poor resources" (De Cock Mbori-Ngacha, Marum). The people of Sub-Saharan Africa should be able to choose to partake in externally funded research programs that are up-to-par with a universal standard of care. ... Soon after AIDS was discovered, AZT was brought back into the medical world and companies started conducting tests with it (Brink). Some believe that AZT is a poison and speeds up the process of HIV, sending a person into full-blown AIDS faster than not taking any medicine at all. Brink believes that AZT is far too toxic for the human body and shows no evidence of ever curing HIV/AIDS. ... Some might agree with Brink in that AZT does not cure HIV/AIDS, but that does not mean it is of no use. ...
Mother-to-child transmission is one of the ways HIV is being spread throughout Africa. ... Antiviral drugs, such as AZT, would greatly assist Sub-Saharan Africa if these types of pharmaceuticals cost less to accommodate this regions poor economy.
People living in Sub-Saharan Africa are limited to approximately twenty dollars worth of healthcare services a year (Lancaster). ... With more people taking these drugs, fewer children would be born with HIV, but that is only one of the possible steps in the approach to stopping the spread of HIV/AIDS. ... Until people can feel unashamed and accepted within their society, they will never tell their partners, thus the spread of HIV/AIDS will continue.
Approximate Word count = 2150 Approximate Pages = 8.6 (250 words per page double spaced)
|
|
|

|
|
|